Opportunities for use of neuroimaging in de-risking drug development and improving clinical outcomes in psychiatry: an industry perspective is a research paper published in Neuropsychopharmacology (2024). On theSindex it has a DataRank of 0. It has been cited 17 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIMH NIH HHS
Grant: DP1 MH116506
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
Grant: R44 MH123373
National Institutes of Health
Grant: 5DP1MH116506-02
A “Circuits-First” Platform for Personalized Neurostimulation Treatment
National Institutes of Health
Grant: 5R44MH123373-03
Validating of Machine Learning-Based EEG Treatment Biomarkers in Depression
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
FWCI
4.17
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords